Patrick Burnett sold $845K of Arcutis Biotherapeutics (ARQT)

Executed Mar 13 2025, disclosed Mar 17 2025, 4 days later.

Value, as filed

$845K

56,395 sh across 2 lots

Executed

Mar 13 2025

the trade date, as filed

Disclosed

Mar 17 2025

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Patrick Burnett See Remarks profile →

Patrick Burnett (See Remarks) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $417K of ARQT (17,250 sh × $24.18, as filed), executed Nov 6 2025.

The name

ARQT

Arcutis Biotherapeutics, Inc. ARQT · Healthcare · 65 filings in 24 months ticker →

Healthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Patrick Burnett in ARQT

ARQTSALE Arcutis Biotherapeutics, Inc. $395K
15,000 sh across 2 lots
Exec Aug 11
Filed Aug 13 · 8:06 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $154K
6,106 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $253K
9,794 sh × $25.81
Exec Feb 4
Filed Feb 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $333K
11,500 sh × $28.94
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $417K
17,250 sh × $24.18
Exec Nov 6 2025
Filed Nov 10 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $346K
23,000 sh × $15.05
Exec Jul 10 2025
Filed Jul 14 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $154K
12,116 sh × $12.70
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. $162K
16,023 sh × $10.14
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET